Manteio Capital’s Myovant Sciences Ltd. MYOV Stock Holding History

Manteio Capital’s Portfolio MYOV Stock Details MYOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-16,326	Closed	-$254K	–	236
2021 Q4	$254K	Buy	+16,326	New	+$312K	0.33%	128

Other funds holding MYOV

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Manteio Capital's MYOV Position: Q1 2022 in Review

Manteio Capital sold out of Myovant Sciences Ltd. (MYOV) in Q1 2022, closing a stake of 16,326 shares — an estimated $254K sold.

Manteio Capital first reported a position in MYOV in Q4 2021 and held it in 1 quarter. The position peaked at $254K in Q4 2021. 89 funds tracked by Wall St. Rank hold MYOV as of Q1 2022.

Manteio Capital reported no remaining Myovant Sciences Ltd. position as of Q1 2022 after selling out during the quarter.
Manteio Capital sold 16,326 Myovant Sciences Ltd. shares in Q1 2022, an estimated $254K.
Manteio Capital first reported a position in Myovant Sciences Ltd. in Q4 2021 and held it in 1 quarter.
Manteio Capital's Myovant Sciences Ltd. position peaked at $254K in Q4 2021.
89 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2022.

Based on Manteio Capital's 13F filing for Q1 2022.